Therapeutic applications of synthetic CpG oligodeoxynucleotides as TLR9 agonists for immune modulation

M Jurk, J Vollmer - BioDrugs, 2007 - Springer
Vertebrate toll-like receptors (TLRs) sense invading pathogens by recognizing bacterial and
viral structures and, as a result, activate innate and adaptive immune responses. Ten human …

CpG oligodeoxynucleotides as TLR9 agonists: therapeutic applications in cancer

YM Murad, TM Clay - BioDrugs, 2009 - Springer
Toll-like receptors (TLRs) are part of the innate immune system, and they belong to the
pattern recognition receptors (PRR) family. The PRR family is designed to recognize and …

Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists

J Vollmer, AM Krieg - Advanced drug delivery reviews, 2009 - Elsevier
Toll-like receptor 9 (TLR9) agonists have demonstrated substantial potential as vaccine
adjuvants, and as mono-or combination therapies for the treatment of cancer and infectious …

Oligodeoxyribonucleotide-based antagonists for Toll-like receptors 7 and 9

D Wang, L Bhagat, D Yu, FG Zhu, JX Tang… - Journal of medicinal …, 2009 - ACS Publications
Oligodeoxyribonucleotides containing unmethylated CpG motifs act as TLR9 agonists. In
this study, we evaluated oligonucleotides containing an unmethylated CpG motif in which …

Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides

G Mutwiri, LA Babiuk - Advanced drug delivery reviews, 2009 - Elsevier
CpG oligodeoxynucleotides (ODN) activate the immune system and are promising
immunotherapeutic agents against infectious diseases, allergy/asthma and cancer. It has …

Antiinfective applications of toll-like receptor 9 agonists

AM Krieg - Proceedings of the American Thoracic Society, 2007 - atsjournals.org
The innate immune system detects pathogens by the presence of highly conserved
pathogen-expressed molecules, which trigger host immune defenses. Toll-like receptor …

Modifications incorporated in CpG motifs of oligodeoxynucleotides lead to antagonist activity of toll-like receptors 7 and 9

D Yu, D Wang, FG Zhu, L Bhagat, M Dai… - Journal of medicinal …, 2009 - ACS Publications
Oligodeoxynucleotides (ODNs) containing unmethylated CpG dinucleotides act as agonists
of TLR9 and induce Th1-type immune responses. In the present study, we synthesized CpG …

Progress in drug development of immunostimulatory CpG oligodeoxynucleotide ligands for TLR9

J Vollmer - Expert opinion on biological therapy, 2005 - Taylor & Francis
Oligodeoxynucleotides (ODNs) with unmethylated deoxycytosine-deoxyguanosine (CpG)
motifs are recognised by Toll-like receptor (TLR) 9 expressed in s-pecialised cell subsets of …

Development of TLR9 agonists for cancer therapy

AM Krieg - The Journal of clinical investigation, 2007 - Am Soc Clin Investig
In vertebrates, the TLRs are a family of specialized immune receptors that induce protective
immune responses when they detect highly conserved pathogen-expressed molecules …

TLR9 agonists: immune mechanisms and therapeutic potential in domestic animals

G Mutwiri - Veterinary immunology and immunopathology, 2012 - Elsevier
Toll like receptors (TLRs) are transmembrane glycoproteins that recognize conserved
microbial molecules. Engagement of TLRs activates innate and adaptive immunity. TLR …